imiquimod has been researched along with Hemangioma, Capillary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, L; Huang, HZ; Li, W; Li, X; Lin, XX | 1 |
| Jia, J; Zhao, YF | 1 |
| Martinez, MI; Mihm, MC; North, PE; Sanchez-Carpintero, I | 1 |
1 review(s) available for imiquimod and Hemangioma, Capillary
| Article | Year |
|---|---|
Biomarkers: important clues to the pathogenesis of infantile haemangioma and their clinical significance.
Topics: AC133 Antigen; Adjuvants, Immunologic; Aminoquinolines; Antigens, CD; Biomarkers; Calcium-Binding Proteins; DNA-Binding Proteins; Female; Glucose Transporter Type 1; Glycoproteins; Hemangioma, Capillary; Humans; Imiquimod; Infant; Microfilament Proteins; Neoplastic Syndromes, Hereditary; Neovascularization, Pathologic; Peptides; Placenta; Pregnancy; Receptors, Androgen; Skin Neoplasms | 2010 |
1 trial(s) available for imiquimod and Hemangioma, Capillary
| Article | Year |
|---|---|
Open-label nonrandomized left-right comparison of imiquimod 5% ointment and timolol maleate 0.5% eye drops in the treatment of proliferating superficial infantile hemangioma.
Topics: Aminoquinolines; Antineoplastic Agents; Extremities; Facial Neoplasms; Female; Hemangioma, Capillary; Humans; Imiquimod; Infant; Male; Neoplastic Syndromes, Hereditary; Non-Randomized Controlled Trials as Topic; Ointments; Ophthalmic Solutions; Skin Neoplasms; Timolol; Torso | 2015 |
1 other study(ies) available for imiquimod and Hemangioma, Capillary
| Article | Year |
|---|---|
Infantile hemangioma: clinical resolution with 5% imiquimod cream.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hemangioma, Capillary; Humans; Imiquimod; Male; Scalp; Skin Neoplasms | 2002 |